Q2 2025 · 13F-HR
GENERAL ATLANTIC, L.P.holdings as filed
Filed 2025-08-14 · accession 0000950142-25-002176
$3.63B
Reported value
15
Positions
2025-06-30
Period end
The Brief · GENERAL ATLANTIC, L.P. · Q2 2025
AI · grounded in 13F
GENERAL ATLANTIC, L.P. established a new position in DLO valued at $724.7M. The fund also initiated new stakes in CHYM for $662.9M and ALHC for $615.9M. Other new additions include XP at $515.5M and AKRO at $306M. Total assets under management stand at $3.6B across 15 positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G29018101 | DLO | DLOCAL | $724.7M | 20.0% | 63,906,695 | Common | SOLE |
| 16935C109 | CHYM | CHIME | $662.9M | 18.3% | 19,208,760 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE | $615.9M | 17.0% | 43,993,323 | Common | SOLE |
| G98239109 | XP | XP, INC | $515.5M | 14.2% | 25,517,733 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS | $306.0M | 8.43% | 5,733,989 | Common | SOLE |
| 01644J108 | ALKT | ALKAMI | $290.7M | 8.01% | 9,645,318 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS | $132.6M | 3.65% | 7,531,252 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS | $127.2M | 3.51% | 9,681,818 | Common | SOLE |
| G9572D103 | BULL | WEBULL | $85.5M | 2.36% | 7,148,051 | Common | SOLE |
| 29882P106 | EWCZ | EUROPEAN WAX CENTER | $73.8M | 2.03% | 13,110,492 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA | $54.0M | 1.49% | 1,500,000 | Common | SOLE |
| M8216R109 | RSKD | RISKIFIED | $26.6M | 0.73% | 5,324,998 | Common | SOLE |
| 005329107 | ADAG | ADAGENE | $7.5M | 0.21% | 3,825,952 | Common | SOLE |
| 022307102 | ALMS | ALUMIS | $3.9M | 0.11% | 1,297,530 | Common | SOLE |
| 39957D201 | GROV | GROVE COLLABORATIVE | $2.8M | 0.08% | 2,474,859 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.